|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.260 AUD | -14.05% |
|
-27.85% | -6.07% |
| 10:55pm | B. Riley Adjusts Price Target on Iperionx to $52 From $58, Maintains Buy Rating | MT |
| 12/03 | IperionX Posts Wider Fiscal H1 Loss; Shares Fall 7% | MT |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: June | 2017 | 2018 | 2019 | 2020 | 2021 (USD) | 2022 (USD) | 2023 (USD) | 2024 (USD) | 2025 (USD) |
|---|---|---|---|---|---|---|---|---|---|
Diversified Metal Ores | |||||||||
Total Assets | 2.79M | 9.91M | 22.8M | 55.44M | 105M | ||||
Interest Expense | - | -44.51K | -78.04K | -123K | -280K | ||||
CAPEX | - | -2.82M | -2.71M | -8.07M | -17.61M | ||||
EBT | - | -21.52M | -17.44M | -21.84M | -35.35M | ||||
D&A | - | 153K | 427K | 646K | 2.28M | ||||
Net Income | - | -21.52M | -17.44M | -21.84M | -35.35M | ||||
Total Assets | - | - | - | - | - | ||||
CAPEX | - | - | - | - | - | ||||
EBT | - | - | - | - | - | ||||
Net Income | - | - | - | - | - |
Geographical Revenue Distribution History
| Fiscal Period: June | 2017 | 2018 | 2019 | 2020 | 2021 (USD) | 2022 (USD) | 2023 (USD) | 2024 (USD) | 2025 (USD) |
|---|---|---|---|---|---|---|---|---|---|
Total Assets | 2.79M | 9.91M | 22.8M | 55.44M | 105M | ||||
Interest Expense | - | -44.51K | -78.04K | -123K | -280K | ||||
D&A | - | 153K | 427K | 646K | 2.28M | ||||
CAPEX | - | -2.82M | -2.71M | -8.07M | -17.61M | ||||
Net Income | - | -21.52M | -17.44M | -21.84M | -35.35M | ||||
EBT | - | -21.52M | -17.44M | -21.84M | -35.35M |
- Stock Market
- Equities
- IPX Stock
- Financials IperionX Limited
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition